Myovant Sciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYOVANT SCIENCES, and what generic alternatives to MYOVANT SCIENCES drugs are available?
MYOVANT SCIENCES has one approved drug.
There are six US patents protecting MYOVANT SCIENCES drugs.
There are one hundred and fifteen patent family members on MYOVANT SCIENCES drugs in thirty-four countries and twenty-eight supplementary protection certificates in fifteen countries.
Summary for Myovant Sciences
| International Patents: | 115 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Myovant Sciences
Expired US Patents for Myovant Sciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Myovant Sciences | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846-001 | May 26, 2021 | 9,346,822 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Myovant Sciences Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Serbia | 63300 | ⤷ Try a Trial |
| Japan | 7043503 | ⤷ Try a Trial |
| Portugal | 2900675 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2018060463 | ⤷ Try a Trial |
| European Patent Office | 3518952 | ⤷ Try a Trial |
| Spain | 2724206 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Myovant Sciences Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1591446 | CR 2021 00048 | Denmark | ⤷ Try a Trial | PRODUCT NAME: RELUGOLIX OR A SALT THEREOF; REG. NO/DATE: EU/1/21/1565 20210720 |
| 0398460 | C300221 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307 |
| 1453521 | C201630040 | Spain | ⤷ Try a Trial | PRODUCT NAME: ETINILESTRADIOL Y MEZCLA DE LEVONORGESTREL Y ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: 80340; DATE OF AUTHORISATION: 20160122; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150211 |
| 1591446 | 672 | Finland | ⤷ Try a Trial | |
| 1591446 | CA 2021 00048 | Denmark | ⤷ Try a Trial | PRODUCT NAME: RELUGOLIX OR A SALT THEREOF; REG. NO/DATE: EU/1/21/1565 20210720 |
| 1591446 | PA2021529 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: RELUGOLIKSAS ARBA JO DRUSKA ; REGISTRATION NO/DATE: EU/1/21/1565 20210716 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
